Your browser doesn't support javascript.
loading
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.
Lee, Jay M; McNamee, Ciaran J; Toloza, Eric; Negrao, Marcelo V; Lin, Jules; Shum, Elaine; Cummings, Amy L; Kris, Mark G; Sepesi, Boris; Bara, Ilze; Kurtsikidze, Nino; Schulze, Katja; Ngiam, Celina; Chaft, Jamie E.
Afiliação
  • Lee JM; Division of Thoracic Surgery, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California. Electronic address: jaymoonlee@mednet.ucla.edu.
  • McNamee CJ; Department of Surgery, Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Toloza E; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; Department of Surgery and Department of Oncologic Sciences, University of South Florida Health Morsani College of Medicine, Tampa, Florida.
  • Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lin J; Section of Thoracic Surgery, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan.
  • Shum E; Division of Hematology and Medical Oncology, Department of Medicine, Perlmutter Cancer Center at NYU Langone Health, New York, New York.
  • Cummings AL; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
  • Kris MG; Thoracic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, New York.
  • Sepesi B; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bara I; US Medical Affairs, Genentech, Inc., South San Francisco, California.
  • Kurtsikidze N; Global Product Development and Medical Affairs Oncology, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Schulze K; Translational Medicine, Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.
  • Ngiam C; US Medical Affairs, Genentech, Inc., South San Francisco, California.
  • Chaft JE; Thoracic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, New York.
J Thorac Oncol ; 18(11): 1458-1477, 2023 11.
Article em En | MEDLINE | ID: mdl-37451404
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article